Islet cell transplantation for patients with unstable or uncontrollable diabetes mellitus a review of clinical effectiveness, cost-effectiveness, and guidelines
Type 1 diabetes is a chronic autoimmune disease characterized by the destruction of pancreatic beta cells which leads to an insulin deficiency. This report aims to provide a summary and critical appraisal of the evidence regarding the clinical effectiveness, cost-effectiveness, and evidence-based gu...
| Main Authors: | , , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
CADTH
2020, April 29, 2020
|
| Edition: | Version 1.0 |
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | Type 1 diabetes is a chronic autoimmune disease characterized by the destruction of pancreatic beta cells which leads to an insulin deficiency. This report aims to provide a summary and critical appraisal of the evidence regarding the clinical effectiveness, cost-effectiveness, and evidence-based guidelines regarding the use of islet cell transplantation in patients with unstable type I diabetes mellitus which was identified in the previous CADTH Reference List report |
|---|---|
| Physical Description: | 1 PDF file (45 pages) illustration |